Why Should Cell & Gene Therapy Companies Consider SAP ERP?
Today's cell and gene therapies are revolutionizing the pharmaceutical sector and treating diseases by changing our bodies on a microscopic level. Organizations manufacturing such therapies face logistic, regulatory, and process orchestration challenges.
SAP for Cell and Gene Therapies empowers Life Sciences companies to streamline, oversee, and optimize their cell and gene therapy supply chain. Helping you deliver the right treatments to the right patients without any errors.
A Single System to Run Your Operations
ERP for Cell and Gene Therapy enables the ability to record and track the end-to-end integrity and traceability of the chain of identity (COI) and chain of custody (COC) of custom medicinal products and orchestrate their supply chain.
The role of SAP ERP for Cell and Gene Therapy is to facilitate, manage, and drive the cell and gene therapy supply chain. It is the hyperconnected conduit between all functions in the supply chain, helping ensure patient orders are fulfilled on time with zero errors.
Key Features for Cell and Gene Therapy
- Workflow management and process visibility, alerts, and notifications
- Business rules and master data management
- Task and exception management
- Audit trail, supply chain visualization, e-signatures, and secure patient data storage
- Chain-of-custody (COC) and chain-of-identity (COI) tracking for end-to-end audit reports and other regulatory purposes
- Event-driven data exchange for connected systems and third-party providers
- Label printing with patient data for identified patient delivery
- Manufacturing integration for in-house production as well as for contract manufacturing organizations (CMOs)
- CMO collaboration and courier integration for supply-chain partners
